Silence Therapeutics

SILENCE THERAPEUTICS PLC-ADR

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

IBM stock

News

Initiation

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

GAIA

STLD

This IBM Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Bernie's Concerns With Healthcare Costs

Long Ideas

MODV

OLMA

Top 3 Health Care Stocks That May Explode In Q4

Soleno Therapeutics (SLNO)

Analyst Color

Biotech

Health Care

Price Target

Movers

General

AMGN

Silence Therapeutics&#39; Phase 2 data shows zerlasiran achieves over 80% Lp(a) reduction in ASCVD patients but faces dosing frequency challenges.

Silence Therapeutics&#39; Zerlasiran Has Competitive Concerns: Analyst

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics PLC

SELINA HOSPITALITY PLC HS

SELINA HOSPITALITY PLC by Selina Hospitality PLC

Selina Hospitality PLC

SILENCE THERAPEUTICS ORD by Silence Therapeutics, Plc.

Southland Holdings Inc

SOLUTION FINL INC by Solution Financial Inc.

Solution Financial Inc

Stabilis Solutions Inc

Soluna Holdings Inc

Soluna Holdings, Inc. - 9.0% Series A Cumulative Perpetual Preferred Stock

STELLA INTL HLDGS LTD ORD by Stella International Holdings Ltd.

Stella International Holdings Ltd

STELLA INTL HLDG UNSP/ADR by Stella International Holdings Ltd.

SALON MEDIA GROUP INC by Salon Media Group, Inc.

Salon Media Group Inc

Soleno Therapeutics Inc

SOLUTIONS 30 SE UNSP/ADR by Solutions 30 S.E.

Solutions 30 SE

Selina Hospitality PLC Warrants (27/10/2027)

SOLANBRIDGE GROUP INC by Solanbridge Group, Inc.

Solanbridge Group Inc

TCW Senior Loan ETF

Press Releases

Silence Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Silence Therapeutics to Webcast Presentations at Upcoming September Investor Conferences

Silence Therapeutics to Participate in Fireside Chat at the Jefferies London Healthcare Conference

Silence Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Silence Therapeutics Presents Late-Breaking Phase 2 Zerlasiran Data at 2024 American Heart Association (AHA) Annual Meeting

Silence Therapeutics to Participate in Fireside Chat at Piper Sandler 36th Annual Healthcare Conference

Silence Therapeutics Presents Promising Phase 1 Data in Polycythemia Vera Patients at the American Society of Hematology (ASH) Annual Meeting

Silence Therapeutics to Report Fourth Quarter and Full Year 2024 Results on February 27, 2025

Silence Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference

Actuate Therapeutics, Inc. - Common stock

Actuate Therapeutics

Alector

Perspective Therapeutics, Inc. Common Stock

Perspective Therapeutics

C4 Therapeutics

Cellectis S.A. - American Depositary Shares

Cellectis

4D Molecular Therapeutics, Inc. - Common Stock

4D Molecular Therapeutics

Greenwich LifeSciences, Inc. - Common stock

Greenwich LifeSciences

Genfit

TuHURA Biosciences

Innate Pharma S.A. - American Depositary Shares

Innate Pharma

Inventiva S.A. - American Depository Shares

Inventiva

Kalaris Therapeutics, Inc. - Common Stock

Kalaris Therapeutics

Kodiak Sciences

Korro Bio

Larimar Therapeutics, Inc. - Common Stock

Larimar Therapeutics

Lexeo Therapeutics

Lyell Immunopharma

Molecular Partners AG - American Depositary Shares

Molecular Partners

Nanobiotix

Puma Biotechnology

Rezolute

Sera Prognostics, Inc. - Class A Common Stock

Sera Prognostics

Protara Therapeutics, Inc. - Common Stock

Protara Therapeutics

TriSalus Life Sciences, Inc. - Common Stock

Comments

Silence Therapeutics

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga